Cheryl Joost Schoder’s Post

Congratulations and good luck to Sanket Shah for launching Otsuka Precision Health, Inc. (OPH). With FDA's new PDURS framework, we are confident a playbook will evolve for molecules and digital medicine to co-exist. It's hard to dismantle molecules from digital medicine. Keeping that in mind, we always conducted our clinical trials to show how JOGO Health + pills provide better outcomes. In one of the clinical trials, we demonstrated that adding JOGO to migraine medications improved MIDAS(Migraine Disability Assessment) score significantly. Another trial demonstrated JOGO's foundational science reduced side effects of cancer medications and medication discontinuation. pill + bytes is where digital medicine is heading.

Our latest blog post is all about biomarker testing, a cutting-edge approach in medical research. Discover how this innovative technique is revolutionizing healthcare and empowering personalized treatments by heading to our website and reading “Breaking the Code: Unmasking Your Health Secrets with Biomarker Testing” today!   #ResearchForLife #RFL #biomarkertesting #biomarker

To deliver better clinical trial results, you need to create a better patient experience. Next-gen clinical trials put patients at the center, leveraging data and analytics, digital technologies and connected devices to identify participants, improve accessibility, accelerate enrolment and drive engagement. Read our Capgemini point of view https://bit.ly/49J9B5N and learn how your organization can break through challenges to create breakthrough innovations.

🌍 𝟭,𝟴𝟬𝟬+ 𝗔𝗧𝗠𝗣 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗧𝗿𝗶𝗮𝗹𝘀 are currently underway worldwide, but only about 100 are in Phase III, the last stage before regulatory approval. 𝗪𝗵𝗮𝘁 𝗰𝗮𝗻 𝘄𝗲 𝗹𝗲𝗮𝗿𝗻 𝗳𝗿𝗼𝗺 𝘁𝗵𝗶𝘀? Since the approval of the first ATMP in 2009, only ~30 ATMP treatments have reached the market. This reveals two realities: - 𝗘𝘅𝗰𝗲𝗽𝘁𝗶𝗼𝗻𝗻𝗮𝗹 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻: ATMPs offer groundbreaking potential and life-changing opportunities, pushing the boundaries of modern medicine. - 𝗦𝗶𝗴𝗻𝗶𝗳𝗶𝗰𝗮𝗻𝘁 𝗖𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲𝘀: High failure rates after Phase I and II, complex regulatory pathways, and logistical hurdles make the journey from trial to approval extremely challenging. Want to explore these challenges and uncover the potential of ATMPs? 👉 Join this 𝗳𝗿𝗲𝗲 webinar on Sept 19th at 4.00 pm CET to dive into the complexities and opportunities of ATMP clinical trials! Let’s make this webinar interactive and valuable for everyone! Share your challenges with running ATMP trials in the comments or via DM, and I'll make sure to address them during the webinar. Register now! 🔗 https://lnkd.in/ey-aCGdg

🌟 More Insights from Regeneron's Digital Biomaker Summit! 🌟 During the panel discussion "Implementing Digital Biomarkers in Clinical Trials", industry experts from Merck, Johnson & Johnson, GSK, and Regeneron shed light on the power of digital biomarkers in shaping the future of healthcare. Here are some key takeaways: 🔍 Bryan J. Hansen, Ph.D. from Johnson & Johnson emphasized the critical need for precision in patient identification, particularly in diseases like Alzheimer's. By leveraging digital biomarkers, Johnson & Johnson is spearheading advancements in precision medicine, enabling early detection and continuous monitoring of patient progress. 💡 Basker G of GSK reminded us of the nuanced nature of clinical trials. Highlighting the importance of patient-centric approaches, Baskar emphasized the need to tailor measurements based on individual patient needs and disease characteristics. After all, no two patients are alike, and understanding their unique QOL needs is paramount in shaping effective interventions. Thank you all for the insightful conversation! Marissa Dockendorf, Bryan J. Hansen, Basker G and Oren Levy 💡 #ClinicalTrial #ClinicalOperations #patientcentric #DigitalBiomakers #precisionmedicine

You’ve heard of clinical trials, but how much do you know about them? Would you consider participating in one? Learn about the pivotal phases of clinical trials, from Exploratory Trials to Post-Marketing Surveillance. Uncover the science behind breakthroughs! Check out our newest blog that explores the basics of clinical trials: https://loom.ly/0GwWmOE #ClinicalTrialPhases #MedicalInnovation #ResearchRevolution

Come join Shaheen E Lakhan, MD, PhD, FAAN and I tomorrow at the Future Health: Best Practices for Advancing Care conference. We are excited to be invited back again this year to share all about the latest advances in prescription digital therapeutics with such a prestigious group! #healthcare #digitalmedicine #digitaltherapeutics #AI

Leading the Way in Medical Innovation: Exploring Germany's Growth Hormone Deficiency Clinical Trial Market! 🌟 Get Info : https://shorturl.at/psKNX 🔍 Explore the breadth and depth of clinical trials addressing GHD within Germany, showcasing a diverse range of research methodologies and therapeutic approaches. 📈 Uncover the latest advancements and breakthroughs emerging from these trials, from novel treatment modalities to predictive biomarkers for early diagnosis. 💊 Discover how these trials are reshaping the landscape of GHD management by optimizing treatment regimens, enhancing patient outcomes, and addressing unmet medical needs. 🌐 Navigate the regulatory framework governing clinical research in Germany, including ethical considerations and patient protections. 💡 Embrace the spirit of collaboration and partnership among academia, industry, and healthcare providers driving forward GHD research and innovation. #ClinicalTrials #GrowthHormoneDeficiency #MedicalResearch #Innovation

Years ago when I started working in patient care I learned how crucial is to publish in peer reviewed, top tier journals. Natera just passed the milestone of 200 peer reviewed publications. Innovation supported by clinical evidence is part of our DNA. #innovation #genomics

Sharing my prospective on how Quest fits in to the complex world of precision medicine.